These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 33224571)

  • 21. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.
    Aref ZF; Bazeed SEES; Hassan MH; Hassan AS; Rashad A; Hassan RG; Abdelmaksoud AA
    Int J Nanomedicine; 2021; 16():4063-4072. PubMed ID: 34163159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media.
    Koyama S; Ueha R; Kondo K
    J Med Internet Res; 2021 Apr; 23(4):e26459. PubMed ID: 33788699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to moderate symptomatic COVID-19 patients-a double-blind, placebo-controlled, clinical trial.
    Srivastava A; Rengaraju M; Srivastava S; Narayanan V; Gupta V; Upadhayay R; Kumar J; Parameswaran S; KanakavalliKadarkarai ; AarthiVelmurugan
    Trials; 2021 Aug; 22(1):570. PubMed ID: 34454572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.
    Gale J; Clark DA; Bohm C; Canney M; Davis I; LeBlanc JJ; Shorter AM; Suri RS; Vinson AJ; West KA; Tennankore KK
    Can J Kidney Health Dis; 2020; 7():2054358120964178. PubMed ID: 33117550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical characteristics in patients with persistent positive pharyngeal swab of omicron variant and analysis on nucleic acid testing of anal swabs].
    Wang X; Liu D; Chen D; Huang F; Tang X; Long L; Zheng X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Sep; 34(9):905-908. PubMed ID: 36377441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
    Marks M; Millat-Martinez P; Ouchi D; Roberts CH; Alemany A; Corbacho-Monné M; Ubals M; Tobias A; Tebé C; Ballana E; Bassat Q; Baro B; Vall-Mayans M; G-Beiras C; Prat N; Ara J; Clotet B; Mitjà O
    Lancet Infect Dis; 2021 May; 21(5):629-636. PubMed ID: 33545090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
    Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
    Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.
    Li J; Zhang C; Wu Z; Wang G; Zhao H
    Trials; 2020 Jun; 21(1):488. PubMed ID: 32503657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulatory role and potential utility of various nutrients and dietary components in SARS-CoV-2 infection.
    Yaseen MO; Jamshaid H; Saif A; Hussain T
    Int J Vitam Nutr Res; 2022 Jan; 92(1):35-48. PubMed ID: 34100300
    [No Abstract]   [Full Text] [Related]  

  • 35. Dietary supplements intake during the second wave of COVID-19 pandemic: A multinational Middle Eastern study.
    Mukattash TL; Alkhalidy H; Alzu'bi B; Abu-Farha R; Itani R; Karout S; Khojah HMJ; Khdour M; El-Dahiyat F; Jarab A
    Eur J Integr Med; 2022 Jan; 49():102102. PubMed ID: 35039757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Taste and Smell are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study.
    Farah Yusuf Mohamud M; Garad Mohamed Y; Mohamed Ali A; Ali Adam B
    Infect Drug Resist; 2020; 13():2631-2635. PubMed ID: 32801800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional supplements for people being treated for active tuberculosis.
    Sinclair D; Abba K; Grobler L; Sudarsanam TD
    Cochrane Database Syst Rev; 2011 Nov; (11):CD006086. PubMed ID: 22071828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Meta-Analysis of 67 Studies with Presenting Symptoms and Laboratory Tests of COVID-19 Patients.
    Mair M; Singhavi H; Pai A; Singhavi J; Gandhi P; Conboy P; Baker A; Das S
    Laryngoscope; 2021 Jun; 131(6):1254-1265. PubMed ID: 33068023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management.
    Abdolsalehi MR; Mahmoudi S; Badv RS; Pourakbari B; Mirnia K; Mahmoudieh Y; Mamishi S
    Infect Disord Drug Targets; 2022; 22(1):e100821195494. PubMed ID: 35135466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutritional support for liver disease.
    Koretz RL; Avenell A; Lipman TO
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.